Table of Content

1 Study Coverage
1.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Introduction
1.2 Market by Type
1.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Region
1.4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players
2.1.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2019-2024)
2.1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2024
2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Sanofi S.A.
3.1.1 Sanofi S.A. Information
3.1.2 Sanofi S.A. Overview
3.1.3 Sanofi S.A. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Gross Margin (2019-2024)
3.1.4 Sanofi S.A. Related Developments
3.2 Reckitt Benckiser Group PLC
3.2.1 Reckitt Benckiser Group PLC Information
3.2.2 Reckitt Benckiser Group PLC Overview
3.2.3 Reckitt Benckiser Group PLC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Gross Margin (2019-2024)
3.2.4 Reckitt Benckiser Group PLC Related Developments
3.3 Pfizer Inc.
3.3.1 Pfizer Inc. Information
3.3.2 Pfizer Inc. Overview
3.3.3 Pfizer Inc. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Gross Margin (2019-2024)
3.3.4 Pfizer Inc. Related Developments
3.4 GlaxoSmithKline Plc
3.4.1 GlaxoSmithKline Plc Information
3.4.2 GlaxoSmithKline Plc Overview
3.4.3 GlaxoSmithKline Plc Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Gross Margin (2019-2024)
3.4.4 GlaxoSmithKline Plc Related Developments
3.5 Sun Pharmaceutical Industries Ltd
3.5.1 Sun Pharmaceutical Industries Ltd Information
3.5.2 Sun Pharmaceutical Industries Ltd Overview
3.5.3 Sun Pharmaceutical Industries Ltd Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Gross Margin (2019-2024)
3.5.4 Sun Pharmaceutical Industries Ltd Related Developments
3.6 Assertio Therapeutics, Inc.
3.6.1 Assertio Therapeutics, Inc. Information
3.6.2 Assertio Therapeutics, Inc. Overview
3.6.3 Assertio Therapeutics, Inc. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Gross Margin (2019-2024)
3.6.4 Assertio Therapeutics, Inc. Related Developments
3.7 Johnson & Johnson
3.7.1 Johnson & Johnson Information
3.7.2 Johnson & Johnson Overview
3.7.3 Johnson & Johnson Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Gross Margin (2019-2024)
3.7.4 Johnson & Johnson Related Developments
3.8 Bayer AG
3.8.1 Bayer AG Information
3.8.2 Bayer AG Overview
3.8.3 Bayer AG Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Gross Margin (2019-2024)
3.8.4 Bayer AG Related Developments
3.9 Horizon Therapeutics plc
3.9.1 Horizon Therapeutics plc Information
3.9.2 Horizon Therapeutics plc Overview
3.9.3 Horizon Therapeutics plc Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Gross Margin (2019-2024)
3.9.4 Horizon Therapeutics plc Related Developments
3.10 Iroko Pharmaceuticals Inc.
3.10.1 Iroko Pharmaceuticals Inc. Information
3.10.2 Iroko Pharmaceuticals Inc. Overview
3.10.3 Iroko Pharmaceuticals Inc. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Gross Margin (2019-2024)
3.10.4 Iroko Pharmaceuticals Inc. Related Developments
4 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Insights
4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue 2019-2024
4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type
5.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Type 2019-2024
6 Market Size by Application
6.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application
6.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application 2019-2024
7 Americas
7.1 Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
7.1.1 Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2019-2024)
7.1.2 Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type (2019-2024)
7.2 Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
7.2.1 Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2019-2024)
7.2.2 Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application (2019-2024)
7.3 Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
7.3.1 Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2019-2024)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
8.1.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2019-2024)
8.1.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type (2019-2024)
8.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
8.2.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2019-2024)
8.2.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application (2019-2024)
8.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
8.3.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2019-2024)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
9.1.1 Asia Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2019-2024)
9.1.2 Asia Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type (2019-2024)
9.2 Asia Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
9.2.1 Asia Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2019-2024)
9.2.2 Asia Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application (2019-2024)
9.3 Asia Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region
9.3.1 Asia Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2019-2024)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
10.1.1 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2019-2024)
10.1.2 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type (2019-2024)
10.2 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
10.2.1 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2019-2024)
10.2.2 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application (2019-2024)
10.3 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
10.3.1 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2019-2024)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends
11.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
11.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
11.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
12 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type
12.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Revenue by Type
12.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size Growth by Type 2024-2030
13 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application
13.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Revenue by Application
13.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size Growth by Application 2024-2030
14 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecasts
14.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue Forecasts 2024-2030
14.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasts Revenue by Region
14.3 Americas
14.4 Europe
14.5 Asia-Pacific
14.6 Middle East & Africa
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer